209 related articles for article (PubMed ID: 10210183)
21. Slow conformational dynamics of the guanine nucleotide-binding protein Ras complexed with the GTP analogue GTPgammaS.
Spoerner M; Nuehs A; Herrmann C; Steiner G; Kalbitzer HR
FEBS J; 2007 Mar; 274(6):1419-33. PubMed ID: 17302736
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of guanosine triphosphate hydrolysis by Ras and Ras-GAP proteins as rationalized by ab initio QM/MM simulations.
Grigorenko BL; Nemukhin AV; Shadrina MS; Topol IA; Burt SK
Proteins; 2007 Feb; 66(2):456-66. PubMed ID: 17094109
[TBL] [Abstract][Full Text] [Related]
23. COMBINE analysis of the specificity of binding of Ras proteins to their effectors.
Tomić S; Bertosa B; Wang T; Wade RC
Proteins; 2007 May; 67(2):435-47. PubMed ID: 17295314
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic amino acid substitutions in the inhibitory rap-1A protein cause it to adopt a ras-p21-like conformation as computed using molecular dynamics.
Chen JM; Brandt-Rauf PW; Pincus MR
J Biomol Struct Dyn; 1996 Jun; 13(6):925-33. PubMed ID: 8832375
[TBL] [Abstract][Full Text] [Related]
25. The effector loop and prenylation site of R-Ras are involved in the regulation of integrin function.
Oertli B; Han J; Marte BM; Sethi T; Downward J; Ginsberg M; Hughes PE
Oncogene; 2000 Oct; 19(43):4961-9. PubMed ID: 11042683
[TBL] [Abstract][Full Text] [Related]
26. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex.
Cui Q; Sulea T; Schrag JD; Munger C; Hung MN; Naïm M; Cygler M; Purisima EO
J Mol Biol; 2008 Jun; 379(4):787-802. PubMed ID: 18479705
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic insertional mutations in the P-loop of Ras are overactive in MAP kinase signaling.
Klockow B; Ahmadian MR; Block C; Wittinghofer A
Oncogene; 2000 Nov; 19(47):5367-76. PubMed ID: 11103938
[TBL] [Abstract][Full Text] [Related]
28. Selection and characterisation of affibody molecules inhibiting the interaction between Ras and Raf in vitro.
Grimm S; Lundberg E; Yu F; Shibasaki S; Vernet E; Skogs M; Nygren PÅ; Gräslund T
N Biotechnol; 2010 Dec; 27(6):766-73. PubMed ID: 20674812
[TBL] [Abstract][Full Text] [Related]
29. Identification of key residues in the A-Raf kinase important for phosphoinositide lipid binding specificity.
Johnson LM; James KM; Chamberlain MD; Anderson DH
Biochemistry; 2005 Mar; 44(9):3432-40. PubMed ID: 15736953
[TBL] [Abstract][Full Text] [Related]
30. Mammalian Sprouty4 suppresses Ras-independent ERK activation by binding to Raf1.
Sasaki A; Taketomi T; Kato R; Saeki K; Nonami A; Sasaki M; Kuriyama M; Saito N; Shibuya M; Yoshimura A
Nat Cell Biol; 2003 May; 5(5):427-32. PubMed ID: 12717443
[TBL] [Abstract][Full Text] [Related]
31. K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12.
Céspedes MV; Sancho FJ; Guerrero S; Parreño M; Casanova I; Pavón MA; Marcuello E; Trias M; Cascante M; Capellà G; Mangues R
Carcinogenesis; 2006 Nov; 27(11):2190-200. PubMed ID: 16679305
[TBL] [Abstract][Full Text] [Related]
32. Modulating the DNA affinity of Elk-1 with computationally selected mutations.
Park S; Boder ET; Saven JG
J Mol Biol; 2005 Apr; 348(1):75-83. PubMed ID: 15808854
[TBL] [Abstract][Full Text] [Related]
33. Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.
Garnett MJ; Rana S; Paterson H; Barford D; Marais R
Mol Cell; 2005 Dec; 20(6):963-9. PubMed ID: 16364920
[TBL] [Abstract][Full Text] [Related]
34. Recognizing and defining true Ras binding domains II: in silico prediction based on homology modelling and energy calculations.
Kiel C; Wohlgemuth S; Rousseau F; Schymkowitz J; Ferkinghoff-Borg J; Wittinghofer F; Serrano L
J Mol Biol; 2005 May; 348(3):759-75. PubMed ID: 15826669
[TBL] [Abstract][Full Text] [Related]
35. Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta.
Du J; Jiang B; Coffey RJ; Barnard J
Mol Cancer Res; 2004 Apr; 2(4):233-41. PubMed ID: 15140945
[TBL] [Abstract][Full Text] [Related]
36. Two phosphorylation-independent sites on the p85 SH2 domains bind A-Raf kinase.
Fang Y; Johnson LM; Mahon ES; Anderson DH
Biochem Biophys Res Commun; 2002 Feb; 290(4):1267-74. PubMed ID: 11812000
[TBL] [Abstract][Full Text] [Related]
37. Role of Raf-1 conserved region 2 in regulation of Ras-dependent Raf-1 activation.
Sendoh H; Hu CD; Wu D; Song C; Yamawaki-Kataoka Y; Kotani J; Okada T; Shima F; Kariya K; Kataoka T
Biochem Biophys Res Commun; 2000 May; 271(3):596-602. PubMed ID: 10814507
[TBL] [Abstract][Full Text] [Related]
38. Domain shuffling as a tool for investigation of protein function: substitution of the cysteine-rich region of Raf kinase and PKC eta for that of yeast Pkc1p.
Schmitz HP; Jöckel J; Block C; Heinisch JJ
J Mol Biol; 2001 Aug; 311(1):1-7. PubMed ID: 11469853
[TBL] [Abstract][Full Text] [Related]
39. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
[TBL] [Abstract][Full Text] [Related]
40. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
